ARTICLE | Clinical News
GDIR agonist: Phase I start
January 14, 2008 8:00 AM UTC
In 2008, Johnson & Johnson's Ortho-McNeil Pharmaceutical Inc. unit will begin Phase I testing of an undisclosed GDIR agonist. The companies said the compound was more potent in preclinical models tha...